When Early Stage Debt Beats Another Equity Round

Two founders run companies that look alike from the outside. Each has a product customers pay for, revenue growing month over month, and roughly a year of cash left. Each has a board asking for a decision soon: raise another round, or take a loan. They reach that fork in the same week, and both have sound reasons for the path they choose. Only one of them chooses well, and what separates them has nothing to do with the cost of capital.

The fork

The first founder’s next milestone is a contract with a large customer that has already signed a letter of intent and scheduled its integration work. When the contract goes live, revenue steps up, and the company’s value, by any method an investor would use, steps up with it. The second founder’s next milestone is proving demand in a new customer segment, a goal that is real but carries no date and no single number.

Both are offered the same choice: a loan sized to cover about a year of burn, or an equity round at a price close to the last one.

Path one, the loan

The table makes the difference look obvious, but neither founder sees it drawn this way at the fork. Both have decks full of confidence, and both believe their milestone is close. The table is what appears when each milestone is forced into the same four rows and no cell is allowed to stay blank.

For the first founder, the loan buys exactly what it is meant to buy. The company reaches the milestone with most of its ownership intact, raises the next round at the higher price, and repays the loan from that round or from the revenue the contract brings in. The warrant costs something, but far less than selling shares at the old price would have.

For the second founder, the loan buys time without a target. Interest falls due every month. Amortization starts on a fixed date whether or not the segment has responded. If the new market takes longer to prove than the loan lasts, the company approaches its next raise with debt on the balance sheet, a secured creditor with a claim on every asset, and investors who must now fund repayment before they fund growth. The debt did not cause the problem. It made the problem more expensive to solve.

Path two, the round

On paper the equity round looks worse for both founders. It sells ownership at the current price, and for the first founder that price is too cheap by exactly the value of a contract about to go live. That cost is real and it is permanent.

For the second founder, the same round is the right instrument. Equity has no repayment date. It is patient by design, and a goal without a date needs patient money. The investors who buy in share the uncertainty over whether the segment works, and they are paid for carrying it through ownership, not through a coupon. The dilution hurts, but it is priced for the risk the company actually faces, and it leaves the company free to take as long as the answer requires.

There is a quieter benefit too. A round forces a conversation with outside investors about whether the new segment is worth chasing at all. A loan skips that conversation, and sometimes the conversation is the most valuable thing the raise produces.

The three conditions

Set the two companies next to each other and the deciding factors separate from the noise. Rate, fees and even the warrant matter less than three properties of the milestone itself.

First, it has to be near. Near means inside the loan’s interest only period, with room left over for delay. A milestone expected after amortization begins is being financed with money that is already leaving.

Second, it has to be measurable. A lender, a board and a new investor all need to agree on whether it happened, from the same statements, without debate. A signed contract billing on schedule qualifies. A shift in how prospects talk about the product does not.

Third, it has to fund its own repayment. Reaching the milestone must either produce the cash to repay the loan directly or lift the company’s value enough that the next round covers repayment with room to spare. A milestone that makes the company more interesting without making it more valuable leaves the loan to be repaid from new equity at the old price, which is precisely what the founder borrowed to avoid.

A milestone that passes two of the three is not a partial yes. Near and measurable but unable to fund repayment is the most common failure, because on the day it happens it looks so much like success.

Why founders pick the wrong path

The second founder usually knows the milestone is vague. What pushes toward debt anyway is how dilution feels. The cost of a loan is spread across months and partly tucked inside a warrant, while the cost of a round arrives as one visible change in the ownership table. Founders compare a vivid loss with a diffuse one and pick the diffuse one.

The first founder’s mistake, when it happens, runs the other way. A founder with a near, measurable milestone sometimes takes the round because equity feels safer, and it is safer in the narrow sense that it never demands repayment. It is also the most expensive way to finance a result that is already largely in hand.

Neither error comes from the terms on offer. Both come from asking which capital is cheaper, when the useful question is what the next milestone is, when it will arrive, and what it will pay for. A board can guard against both errors by asking each founder to fill in the same table before any term sheet arrives.

Borrow only when the thing the loan is paying to reach will arrive before the principal payments start, can be read off a statement by everyone at the table, and leaves the company able to repay out of what reaching it produces.